A 2023 study published in Scientific Reports analyzed over 68,250 Reddit posts related to GLP1 medications and recruited 153 participants with obesity
Current Reality: Existing pre-made supplies may be available until they expire, but new patient access is very limited
According to their respective PK profiles, exenatide BID and lixisenatide can be categorized as short-acting agents (each has a half-life of 35 h) compared with the long-acting agents liraglutide, exenatide LAR, albiglutide, and dulaglutide, which have half-lives ranging from 12 h to several days [16]
[14] Reports of systemic skin lightening with GSH have appeared with increasing frequency on social media, and clinics advertise it online in many countries (Africa, the USA, Canada, Mexico, etc.)
Mounjaro is currently supplied as an injection, not a tablet